Home › Compare › NPMFF vs ABBV
NPMFF yields 66666666.67% · ABBV yields 3.06%● Live data
📍 NPMFF pulled ahead of the other in Year 1
Combined, NPMFF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NPMFF + ABBV for your $10,000?
NewPeak Metals Limited, a mineral resource company, explores for and evaluates gold properties in Finland, New Zealand, and Argentina. Its project portfolio includes the Las Opeñas Gold project covering an area of 1,462 hectares located in the north-western region of San Juan province, Argentina; and Cachi Gold project covering an area of 46,892 hectares lease package located in the central-western region of Santa Cruz province, Argentina. The company also holds 100% interest in the Somero and Tampere Gold Project covering a total area of 286 hectares located in Finland; and holds interest in the Bergslagen Tungsten project covering a total area of 11,870 hectares located near the city of Grängesberg, Sweden. In addition, it owns approximately 22.10% interest in Lakes Blue Energy which has petroleum assets located in Victoria, Queensland, South Australia, and Papua New Guinea. The company was formerly known as Dark Horse Resources Limited and changed its name to NewPeak Metals Limited in September 2020. NewPeak Metals Limited was incorporated in 1995 and is based in Brisbane, Australia.
Full NPMFF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.